HGF and cancer: Vascular endothelial growth factor (VEGF), fibroblast growth factor 1 (FGF) and hepatocyte growth factor (HGF) are primary growth factors that promote angiogenesis.3 Currently, most inhibitors for the anti‐angiogenic treatment of advanced cancer in clinical trials mainly target VEGF or its receptors (VEGFR).3 However, the performance of these agents is still disappointing.